This company has been marked as potentially delisted and may not be actively trading. Acorda Therapeutics (ACOR) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Acorda Therapeutics Short Interest DataAcorda Therapeutics (ACOR) has a short interest of 8,100 shares, representing 0.66% of the float (the number of shares available for trading by the public). This marks a -14.74% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 119,299 shares to cover all short positions.Current Short Interest8,100 sharesPrevious Short Interest9,500 sharesChange Vs. Previous Month-14.74%Dollar Volume Sold Short$107,009.10Short Interest Ratio0.1 Days to CoverLast Record DateMarch 31, 2024Outstanding Shares1,240,000 sharesFloat Size1,230,000 sharesShort Percent of Float0.66%Today's Trading Volume416,900 sharesAverage Trading Volume119,299 sharesToday's Volume Vs. Average349% Short Selling Acorda Therapeutics? Sign up to receive the latest short interest report for Acorda Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACOR Short Interest Over TimeACOR Days to Cover Over TimeACOR Percentage of Float Shorted Over Time Acorda Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20248,100 shares $107,009.10 -14.7%0.7%0.1 $13.21 3/15/20249,500 shares $117,800.00 -14.4%0.8%2.5 $12.40 2/29/202411,100 shares $150,961.11 +7.8%0.9%2.4 $13.60 2/15/202410,300 shares $156,560.00 -3.7%0.8%2.4 $15.20 1/31/202410,700 shares $171,414.00 -12.3%0.9%2.5 $16.02 1/15/202412,200 shares $192,760.00 +54.4%1.0%2.8 $15.80 12/31/20237,900 shares $119,211.00 -39.7%0.6%1.5 $15.09 12/15/202313,100 shares $193,880.00 -21.1%1.1%2.1 $14.80 11/30/202316,600 shares $169,984.00 +22.1%1.4%2.5 $10.24 11/15/202313,600 shares $134,640.00 +3.0%1.1%1.9 $9.90 Get the Latest News and Ratings for ACOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acorda Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202313,200 shares $126,456.00 -9.6%1.1%1.7 $9.58 10/15/202314,600 shares $146,000.00 +50.5%1.2%1.6 $10.00 9/30/20239,700 shares $145,403.00 -27.1%0.8%1 $14.99 9/15/202313,300 shares $204,155.00 +95.6%1.1%1.5 $15.35 8/31/20236,800 shares $84,354.00 -47.3%0.6%0.4 $12.41 8/15/202312,900 shares $215,430.00 -21.3%1.1%0.7 $16.70 7/31/202316,400 shares $251,658.00 -21.5%1.4%0.3 $15.35 7/15/202320,900 shares $323,532.00 -12.2%1.7%0.4 $15.48 6/30/202323,800 shares $309,638.00 +25.3%2.0%0.4 $13.01 6/15/202319,000 shares $226,100.00 +63.8%1.6%0.4 $11.90 5/31/202311,600 shares $139,200.00 -97.1%1.0%0.3 $12.00 5/15/2023396,800 shares $249,428.48 +100.0%N/A0.5 $0.63 4/30/2023198,400 shares $92,256.00 -1.0%N/A0.3 $0.47 4/15/2023200,400 shares $106,212.00 +59.6%N/A1.6 $0.53 3/31/2023125,600 shares $73,601.60 -51.1%N/A0.7 $0.59 3/15/2023256,700 shares $160,437.50 -7.4%N/A1.2 $0.63 2/28/2023277,100 shares $250,359.85 +12.8%N/A1.4 $0.90 2/15/2023245,600 shares $225,952.00 -26.3%N/A1.2 $0.92 1/31/2023333,400 shares $316,730.00 -23.1%N/A1.2 $0.95 1/15/2023433,800 shares $364,695.66 -1.1%N/A0.3 $0.84 12/30/2022438,500 shares $336,197.95 -8.2%N/A0.1 $0.77 12/15/2022477,400 shares $262,570.00 -13.5%N/A0.1 $0.55 11/30/2022551,600 shares $352,362.08 -30.8%N/A0.1 $0.64 11/15/2022796,800 shares $520,230.72 -45.8%N/A0.2 $0.65 10/31/20221,470,000 shares $1.57 million +85.6%N/A0.4 $1.07 10/15/2022792,000 shares $265,557.60 +230.3%N/A0.3 $0.34 9/30/2022239,800 shares $71,700.20 +8.1%N/A0.7 $0.30 9/15/2022221,800 shares $88,720.00 -5.7%N/A0.7 $0.40 8/31/2022235,100 shares $95,497.62 +44.1%N/A0.2 $0.41 8/15/2022163,200 shares $76,638.72 -23.1%N/A0.1 $0.47White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 7/31/2022212,200 shares $92,307.00 -34.2%N/A0.1 $0.44 7/15/2022322,600 shares $144,524.80 +2.1%N/A0.2 $0.45 6/30/2022316,000 shares $147,192.80 +45.7%N/A0.2 $0.47 6/15/2022216,900 shares $86,846.76 -85.0%N/A0.1 $0.40 5/31/20221,450,000 shares $738,050.00 +458.3%N/A3.3 $0.51 5/15/2022259,700 shares $191,762.48 +204.5%N/A2.7 $0.74 4/30/202285,300 shares $116,008.00 -27.5%N/A1.4 $1.36 4/15/2022117,700 shares $182,435.00 -17.8%N/A1.9 $1.55 3/31/2022143,200 shares $230,552.00 -26.2%N/A2 $1.61 3/15/2022194,100 shares $324,147.00 -12.1%N/A2.3 $1.67 2/28/2022220,900 shares $452,845.00 -3.8%N/A2.4 $2.05 2/15/2022229,500 shares $472,770.00 -18.7%N/A1.9 $2.06 1/31/2022282,400 shares $522,440.00 +2.9%N/A2 $1.85 1/15/2022274,400 shares $592,704.00 +9.8%N/A1.8 $2.16 12/31/2021250,000 shares $597,500.00 +2.5%N/A1.7 $2.39 12/15/2021243,900 shares $631,701.00 -74.1%N/A1.6 $2.59 11/30/2021940,600 shares $2.45 million +60.2%N/A6.3 $2.60 11/15/2021587,000 shares $2.10 million +34.9%N/A4.1 $3.57 10/29/2021435,000 shares $1.77 million +2.8%N/A3 $4.07 10/15/2021423,000 shares $1.99 million -25.8%N/A2.1 $4.71 9/30/2021570,400 shares $2.62 million -24.7%N/A0.5 $4.60 9/15/2021757,900 shares $3.52 million -19.3%N/A0.7 $4.65 8/31/2021939,400 shares $3.97 million -33.4%N/A0.8 $4.23 8/13/20211,410,000 shares $5.05 million +18.5%15.2%1.2 $3.58 7/30/20211,190,000 shares $4.46 million +100.1%12.8%1.1 $3.75 7/15/2021594,800 shares $2.31 million -12.0%6.4%0.6 $3.88 6/30/2021675,600 shares $3.22 million -15.0%7.3%2.8 $4.77 6/15/2021794,700 shares $3.32 million -44.4%8.6%3.4 $4.18 5/28/20211,430,000 shares $5.32 million +18.2%15.4%7.9 $3.72 5/14/20211,210,000 shares $5.17 million +1.7%13.0%6.2 $4.27 4/30/20211,190,000 shares $5.78 million -4.0%12.8%5.1 $4.86 4/15/20211,240,000 shares $5.08 million +6.9%13.4%4.5 $4.10 3/31/20211,160,000 shares $5.63 million +8.4%12.5%1.2 $4.85 3/15/20211,070,000 shares $6.27 million +40.6%11.5%1 $5.86 2/26/2021761,100 shares $4.60 million +1.5%8.2%0.7 $6.05 2/12/2021750,200 shares $5.69 million +39.1%8.0%0.7 $7.59 1/29/2021539,400 shares $3.72 million -50.1%5.8%0.5 $6.90 1/15/20211,080,000 shares $6.88 million -56.8%11.6%0.9 $6.37 12/31/20202,500,000 shares $10.65 million -4.2%31.9%3 $4.26 12/15/20202,610,000 shares $11.25 million -68.6%5.5%0.4 $4.31 11/30/20208,320,000 shares $34.52 million +53.5%17.7%1.3 $4.15 11/15/20205,420,000 shares $27.10 million -25.1%11.5%0.9 $5.00 10/30/20207,240,000 shares $39.75 million -25.1%15.4%1.2 $5.49 10/15/20209,660,000 shares $40.56 million -23.3%20.5%1.7 $4.20 9/30/202012,600,000 shares $38.93 million +24.9%26.7%3.1 $3.09 9/15/202010,090,000 shares $30.86 million -8.3%21.4%4.9 $3.06 8/31/202011,000,000 shares $36.72 million +9.8%23.3%5.2 $3.34 8/14/202010,020,000 shares $40.28 million +2.0%21.2%4.2 $4.02 7/31/20209,820,000 shares $37.05 million +2.4%20.8%3.7 $3.77 7/15/20209,590,000 shares $43.69 million +5.2%20.3%3.9 $4.56White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 6/30/20209,120,000 shares $40.20 million -12.2%19.3%4.6 $4.41 6/15/202010,390,000 shares $53.06 million +23.8%22.0%5.4 $5.11 5/29/20208,390,000 shares $38.70 million -19.1%17.8%4.6 $4.61 5/15/202010,370,000 shares $48.78 million -26.9%22.0%6.4 $4.70 ACOR Short Interest - Frequently Asked Questions What is Acorda Therapeutics' current short interest? Short interest is the volume of Acorda Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 8,100 shares of ACOR short. 0.66% of Acorda Therapeutics' shares are currently sold short. Learn More on Acorda Therapeutics' current short interest. What is a good short interest percentage for Acorda Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.66% of Acorda Therapeutics' floating shares are currently sold short. Is Acorda Therapeutics' short interest increasing or decreasing? Acorda Therapeutics saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 8,100 shares, a decrease of 14.7% from the previous total of 9,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acorda Therapeutics' float size? Acorda Therapeutics currently has issued a total of 1,240,000 shares. Some of Acorda Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acorda Therapeutics currently has a public float of 1,230,000 shares. How does Acorda Therapeutics' short interest compare to its competitors? 0.66% of Acorda Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Acorda Therapeutics: Molecular Templates, Inc. (5.48%), Amgen Inc. (2.71%), Vertex Pharmaceuticals Incorporated (1.70%), Gilead Sciences, Inc. (1.62%), Regeneron Pharmaceuticals, Inc. (2.57%), Alnylam Pharmaceuticals, Inc. (2.40%), Biogen Inc. (2.37%), United Therapeutics Co. (3.77%), Incyte Co. (3.90%), BioMarin Pharmaceutical Inc. (2.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Acorda Therapeutics stock? Short selling ACOR is an investing strategy that aims to generate trading profit from Acorda Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acorda Therapeutics? A short squeeze for Acorda Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACOR, which in turn drives the price of the stock up even further. How often is Acorda Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACOR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies Molecular Templates Short Interest Data Amgen Short Interest Data Vertex Pharmaceuticals Short Interest Data Gilead Sciences Short Interest Data Regeneron Pharmaceuticals Short Interest Data Alnylam Pharmaceuticals Short Interest Data Biogen Short Interest Data United Therapeutics Short Interest Data Incyte Short Interest Data BioMarin Pharmaceutical Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACOR) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredYou Were Looted.While you were saving and investing the right way… they were rewriting the rules behind closed doors. Now 5...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acorda Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acorda Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
